Listen "Marilyn Huestis on Designer Drugs"
Episode Synopsis
In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can in the February issue of CPT focused on Designer Drugs.
Listen and subscribe for free on iTunes and Google Play
Listen and subscribe for free on iTunes and Google Play
More episodes of the podcast ASCPT Podcast Channel
CTS Call for Papers: Biomarkers
19/05/2025
Bench to Budget: CPT’s Latest Themed Issue
30/04/2025
CTS AI/ML
10/04/2025
Wiley OA Agreements
27/03/2025
PSP Launches MBMA Call for Papers
19/02/2025